Hepatoblastoma is the most common liver cancer in children. With modern chemotherapy, advanced surgery, and expert multidisciplinary care, most children can be cured and return to healthy lives.
Most children diagnosed before age three
Powerful tumor marker used for monitoring
International treatment protocol followed
Excellent outcomes with surgery and chemotherapy
Especially children born with very low birth weight.
A growth disorder associated with increased tumor risk.
When one side of the body grows larger than the other.
Firm mass noticed during bathing or dressing.
Refusal to eat or progressive weight loss.
Persistent digestive symptoms requiring evaluation.
Yellow discoloration of eyes or skin.
Rare hormone-producing tumors may trigger this.
Alpha-Fetoprotein (AFP) is one of the most important markers in Hepatoblastoma. AFP levels are often dramatically elevated and help us:
Most of liver remains unaffected.
Limited liver involvement.
More extensive disease requiring careful planning.
Advanced disease often needing transplant consideration.
Shrinks the tumor and makes surgery safer.
Partial hepatectomy or liver transplant when necessary.
Additional treatment to maximize cure rates.
Monitoring and preventive strategies during Cisplatin therapy.
Advanced hydration protocols to reduce toxicity.
Specialized feeding guidance before and after surgery.
Access to leading pediatric liver transplant centers.
Yes. Many children achieve cure with chemotherapy and complete surgical removal.
Yes. The liver has remarkable regenerative ability after surgery.
No. Most children can be treated with tumor resection. Transplant is reserved for selected advanced cases.
If you notice unexplained abdominal swelling, weight loss, or abnormal liver imaging, consult Dr. Nishant Dharsandiya for expert evaluation and treatment planning.
Schedule Consultation